Huons partners with Sanofi Korea to enter vaccine market

Huons, a subsidiary of Huons Group, said Wednesday it has signed a distribution and co-promotion agreement with Sanofi Korea to enter the domestic vaccine market. Under the deal, effective April 1, Huons will take charge of nationwide distribution and joint marketing of five vaccines developed by Sanofi. The portfolio includes influenza vaccines Vaxigrip, a standard-dose vaccine for the general population, and Efluelda, a high-dose vaccine designed to provide stronger immune protection for older adults, as well as adult vaccines such as the Tdap vaccine Adacel, hepatitis A vaccine Avaxim and meningococcal vaccine MenQuadfi. The partnership marks a strategic move by Huons to expand into the vaccine segment, leveraging Sanofi’s global product lineup alongside its own expertise in injectable drug sales and cold chain logistics. To support the new business, Huons has recently established a dedicated vaccine unit aimed at strengthening its sales capabilities and expanding access to vaccines among health care providers and patients in Korea. The company said it will focus on ensuring stable nWeiter zum vollständigen Artikel bei Korea Times Weiter zum vollständigen Artikel bei Korea Times